行业
一位短发灰白、戴眼镜的男士,身着深色西装外套与白色衬衫,在现代化的公司法律事务所场景中对着镜头微笑。

约瑟夫-P-米拉

合伙人/退休

约瑟夫-P-米拉

合伙人/退休

约瑟夫·P·米拉博士为化工、制药及生物技术行业的客户提供国内外知识产权战略咨询。他担任本所化学、生物技术与制药业务部、医疗保健与生命科学及能源业务部、食品饮料行业团队的合伙人。

Joe’s practice extends to all aspects of IP portfolio management, patent procurement, non-infringement, freedom to operate and invalidity opinions, due diligence, and licensing. In addition, Joe has been actively involved in appeals to the board of the U.S. Patent and Trademark Office as well as ex parte reexaminations and Patent Office Trials, serving as lead counsel for inter partes review proceedings both opposing and defending patents.

Joe’s practice spans a wide array of technical areas including pharmaceuticals and drug delivery, biotechnology, nanotechnology, and personalized medicine. He has extensive experience in renewable energy technology including biofuels and batteries, and in chemical and biochemical fields such as peptides, proteins, modified nucleotides and oligonucleotides, organic and enzymatic synthetic methods, catalysts, electrochemistry, composites, adhesives, and polymers.

Joe’s scientific experience includes several leadership positions at Molecumetics, Ltd., a start-up pharmaceutical company, where he served as intellectual property manager, project leader, and senior scientist. His research involved the design and synthesis of protease inhibitors, including antithrombotics and antibacterials. His chemical knowledge includes organic and peptide synthesis, combinatorial chemistry, and the use of solid-phase and high-throughput synthesis techniques in the creation of complex heterocyclic compounds.

附属机构

  • 美国知识产权法协会会员
  • Member, American Chemical Society
2023年1月17日 新闻速递

规则的例外?根据《联邦法规》第37编第42.123(b)条作为补充信息提交证据的迟延

通过Foley的员工休假管理计划,确保符合《美国残疾人法案》和《家庭医疗休假法案》要求,该计划专为管理职场休假的HR和法律团队设计。
2022年9月12日 博客

规则的例外?根据《联邦法规》第37编第42.123(b)条作为补充信息提交证据的迟延

在专利审判与上诉委员会(PTAB)的审判中,相关规则规定了当事人何时可提交证据,以确保对方当事人获得公平的机会对此类证据作出回应。
2022年5月6日 专利审判与上诉委员会审判洞察

知识产权风险:多份同时提交请愿书的禁反言陷阱

在直觉外科公司诉Ethicon有限责任公司一案中,美国联邦巡回上诉法院近日确认,根据《美国法典》第35编第315(e)(1)条规定的禁反言原则,可适用于同时提交但未同时裁决的多方复审程序之间。
May 29, 2020 In the News

Meara Quoted in Law360 About Proposed USPTO Rule on Evidence

Partner Joseph Meara was quoted in the Law360 article, “IP Owners Approach USPTO Evidence Proposal With Caution,” about how patent owners may be able to harness a recent rule proposed by the U.S. Patent and Trademark Office to get America Invents Act challenges thrown out early.
May 29, 2020 In the News

Meara Quoted in BioWorld About Proposed PTO Rulemaking Post SAS v Iancu

Partner Joseph Meara was quoted in the BioWorld article, “Presumption in favor of petitioner seen as most critical piece of PTO response to SAS v. Iancu,” about the U.S. Patent and Trademark Office’s notice of proposed rulemaking in response to the 2018 decision in the U.S. Supreme Court decision SAS v. Iancu.
2020年5月27日 博客

专利审判与上诉委员会拟议规则变更:故伎重演?

2020年5月27日,美国专利商标局(USPTO)在《联邦公报》上公布了一套新的拟议规则修订方案,该方案主要规范了专利审判与上诉委员会(PTAB)审理争议案件的程序。